Shares of Auxilium Pharmaceuticals (AUXL -12.8%) take a big hit today on a disappointing Q1...

|About: Auxilium Pharmaceuticals, Inc. (AUXL)|By:, SA News Editor

Shares of Auxilium Pharmaceuticals (AUXL -12.8%) take a big hit today on a disappointing Q1 report, missing on both EPS and revenue. The company cites some some "unanticipated challenges" with its commercial franchises for the miss. For FY13, its expects revenues of $360M - $415M, which reflects the closing of the acquisition of Actient, and may not be comparable to consensus estimates of $334.34M.